Mohr Audrey, Malhotra Rajneesh, Mayer Gaell, Gorochov Guy, Miyara Makoto
Sorbonne Université Inserm Centre d'immunologie et des maladies infectieuses-Paris (Cimi-Paris) AP-HP Hôpital Pitié-Salpêtrière Paris France.
Immunity department RIA IMED Biotech Unit AstraZeneca Gothenburg Mölndal Sweden.
Clin Transl Immunology. 2018 Jan 30;7(1):e1005. doi: 10.1002/cti2.1005. eCollection 2018.
FOXP3-expressing CD4 T regulatory (Treg) cells are instrumental for the maintenance of self-tolerance. They are also involved in the prevention of allergy, allograft rejection, foetal rejection during pregnancy and of exaggerated immune response towards commensal pathogens in mucosal tissues. They can also prevent immune responses against tumors and promote tumor progression. FOXP3-expressing Treg cells are not a homogenous population. The different subsets of Treg cells can have different functions or roles in the maintenance of immune homeostasis and can therefore be differentially targeted in the management of autoimmune diseases or in cancer. We discuss here how Treg cell subsets can be differentiated phenotypically, functionally and developmentally in humans.
表达叉头框蛋白3(FOXP3)的CD4调节性T(Treg)细胞对于维持自身耐受性至关重要。它们还参与预防过敏、同种异体移植排斥反应、孕期胎儿排斥反应以及黏膜组织中对共生病原体的过度免疫反应。它们也能预防针对肿瘤的免疫反应并促进肿瘤进展。表达FOXP3的Treg细胞并非同质群体。Treg细胞的不同亚群在维持免疫稳态中可能具有不同功能或作用,因此在自身免疫性疾病或癌症的治疗中可以有针对性地进行不同处理。我们在此讨论人类Treg细胞亚群在表型、功能和发育方面如何进行区分。